Treatments | CTL | EX | EXA | EXF | XAF-1 | XAF-2 | XAF-3 | XAF-4 |
|---|
EX | 0 | 54 (600) | 54 (600) | 54 (600) | 54 (600) | 63 (700) | 63 (700) | 54 (600) |
EA | 0 | 0 | 5 (500) | 0 | 5 (500) | 6 (600) | 4 (400) | 6.7 (668) |
EF | 0 | 0 | 0 | 0.4 (400) | 0.4 (400) | 0.5 (500) | 0.5 (500) | 0.4 (400) |
- aTreatments: CTL, basal diet (control); EX, basal diet supplemented with core xylanase; EXA, basal diet supplemented with xylanase accompanied by EA; EXF, basal diet supplemented with xylanase accompanied by EF; XAF-i (i = 1–4), compound groups with the above three enzymes. The same as below, also involving all figures. Bold values in parentheses are additive dosages (mg/kg) in this animal experiment, while the values outside brackets are the appropriate inclusion levels (U/g) obtained from the in vitro screening process
